Mutual Fund Details

Bajaj Finserv Healthcare Fund Direct-Growth

Equity Pharma

NAV

₹12.0150

as on 16 Sep 2026, 11:18 PM

₹-0.0690(0.57%)

Last Change

Download the Paytm Money app now!

Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.

Zero brokerage for 30 days
Zero account opening fees
Zero AMC for life

Scan QR code to download the app

Investment Performance

would have given a return of

₹1,03,499

₹1,06,749

₹1,20,815

₹1,22,849

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹22,849

Profit (absolute return)

22.85%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 1 month

3.42%

In the last 3 months

15.22%

In the last 6 months

26.61%

In the last 1 year

22.85%

In the last 3 years

In the last 5 years

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

Bajaj Finserv Healthcare Fund Direct-Growth

as of 31 Aug 2026, 05:30 AM

₹405.91 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

1% for redemption within 3 Months

0.90%

Expense Ratio

Plan

Growth

0.57%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

1% for redemption within 3 Months

Scheme Document

View

Sectors Holding in this Mutual Fund

as on31 Aug 2026

Sort By

Value

Sector

Healthcare

88.25%

₹358.22 Cr

Consumer Staples

2.27%

₹9.21 Cr

Materials

2.00%

₹8.12 Cr

Chemicals

1.45%

₹5.89 Cr

Financial

0.92%

₹3.73 Cr

Others

5.11%

₹20.74 Cr

View All

Sectors Holding in this Mutual Fund

as on31 Aug 2026

Sort By

Value

Sector

Healthcare

88.25%

₹358.22 Cr

Consumer Staples

2.27%

₹9.21 Cr

Materials

2.00%

₹8.12 Cr

Chemicals

1.45%

₹5.89 Cr

Financial

0.92%

₹3.73 Cr

Others

5.11%

₹20.74 Cr

View All

Companies Holding in this Mutual Fund

as on31 Aug 2026

Sort By

Value

Company

Divi's Laboratories Ltd.

10.55%

₹42.82 Cr

Sun Pharmaceutical Industries Ltd.

8.21%

₹33.33 Cr

Rubicon Research Ltd.

6.81%

₹27.64 Cr

Piramal Pharma Ltd.

6.72%

₹27.28 Cr

Aurobindo Pharma Ltd.

6.18%

₹25.09 Cr

Others

61.53%

₹249.76 Cr

View All

Companies Holding in this Mutual Fund

as on31 Aug 2026

Sort By

Value

Company

Divi's Laboratories Ltd.

10.55%

₹42.82 Cr

Sun Pharmaceutical Industries Ltd.

8.21%

₹33.33 Cr

Rubicon Research Ltd.

6.81%

₹27.64 Cr

Piramal Pharma Ltd.

6.72%

₹27.28 Cr

Aurobindo Pharma Ltd.

6.18%

₹25.09 Cr

Others

61.53%

₹249.76 Cr

View All

Funds in this Category

This fund's returns:

21.98%

Return Duration

1 Year

Kotak Healthcare Fund Direct - Growth

HDFC Pharma And Healthcare Fund Direct - Growth

PGIM India Healthcare Fund Direct-Growth

AboutBajaj Finserv Healthcare Fund Direct-Growth

Bajaj Finserv Healthcare Fund Direct-Growth is aEquity mutual fund scheme fromBajaj Finserv Mutual Fund. This scheme was launched onInvalid date. It has an AUM of ₹405.91 Crores and the latest NAV decalared is ₹12.015 as on17 Sep 2026 at11:12 am.

Bajaj Finserv Healthcare Fund Direct-Growth scheme return performance in last 1 year is 22.85%, is 20.38% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.